408 related articles for article (PubMed ID: 15793112)
1. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical caspofungin in experimental fusarium keratitis.
Ozturk F; Yavas GF; Kusbeci T; Cetinkaya Z; Inan UU; Ermis SS; Kiraz N
Cornea; 2007 Jul; 26(6):726-8. PubMed ID: 17592325
[TBL] [Abstract][Full Text] [Related]
3. The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
Kusbeci T; Avci B; Cetinkaya Z; Ozturk F; Yavas G; Ermis SS; Inan UU
Curr Eye Res; 2007 Jan; 32(1):57-64. PubMed ID: 17364736
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
Roy G; Galigama RD; Thorat VS; Mallela LS; Roy S; Garg P; Venuganti VVK
Int J Pharm; 2019 Dec; 572():118808. PubMed ID: 31678387
[TBL] [Abstract][Full Text] [Related]
5. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
Hiraoka T; Kaji Y; Wakabayashi T; Nanbu PN; Okamoto F; Oshika T
Cornea; 2007 Apr; 26(3):336-42. PubMed ID: 17413962
[TBL] [Abstract][Full Text] [Related]
6. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicans-induced keratomycosis in rabbits.
Pleyer U; Legmann A; Mondino BJ; Lee DA
Am J Ophthalmol; 1992 Mar; 113(3):303-8. PubMed ID: 1543224
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole.
Neoh CF; Leung L; Vajpayee RB; Stewart K; Kong DC
Ann Pharmacother; 2011 May; 45(5):e24. PubMed ID: 21521864
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans.
Hossain MA; Reyes GH; Long LA; Mukherjee PK; Ghannoum MA
J Antimicrob Chemother; 2003 Jun; 51(6):1427-9. PubMed ID: 12716772
[TBL] [Abstract][Full Text] [Related]
10. Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.
Hassan HA; Geniady MM; Abdelwahab SF; Abd-Elghany MI; Sarhan HA; Abdelghany AA; Kamel MS; Rodriguez AE; Alio JL
Ophthalmic Res; 2018; 60(2):69-79. PubMed ID: 29969774
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
[No Abstract] [Full Text] [Related]
12. Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B:
Mahfud MAS; Syahirah NA; Akram M; Mahfufah U; Saputra MD; Elim D; Andi MNF; Sultan NAF; Himawan A; Domínguez-Robles J; Pamornpathomkul B; Mir M; Permana AD
Mol Pharm; 2023 Dec; 20(12):6246-6261. PubMed ID: 37975721
[TBL] [Abstract][Full Text] [Related]
13. Differences in response in vivo to amphotericin B among Candida albicans strains.
O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138
[TBL] [Abstract][Full Text] [Related]
14. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
[TBL] [Abstract][Full Text] [Related]
15. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
Wasan KM; Sivak O; Rosland M; Risovic V; Bartlett K
J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
[TBL] [Abstract][Full Text] [Related]
16. Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.
Mahdy RA; Nada WM; Wageh MM
J Ocul Pharmacol Ther; 2010 Jun; 26(3):281-5. PubMed ID: 20565316
[TBL] [Abstract][Full Text] [Related]
17. Orally administered antifungal therapy for experimental keratomycosis.
O'Day DM
Trans Am Ophthalmol Soc; 1990; 88():685-725. PubMed ID: 2095036
[TBL] [Abstract][Full Text] [Related]
18. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
[TBL] [Abstract][Full Text] [Related]
19. Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole.
Hurtado-Sarrió M; Duch-Samper A; Cisneros-Lanuza A; Díaz-Llopis M; Peman-Garcíia J; Vazquez-Polo A
Arch Ophthalmol; 2010 Jul; 128(7):941-2. PubMed ID: 20625061
[No Abstract] [Full Text] [Related]
20. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
